The teratogenic activity of a thalidomide analogue, EM 12  in rabbits, rats, and monkeys.
D000014:Abnormalities, Drug-Induced; D000818:Animals; D001848:Bone Diseases, Developmental / Q000139:chemically induced; D001842:Bone and Bones / Q000002:abnormalities; D005260:Female; D005313:Fetal Death / Q000139:chemically induced; D005315:Fetal Diseases / Q000139:chemically induced; D005552:Forelimb / Q000002:abnormalities; D005865:Gestational Age; D000882:Haplorhini; D006614:Hindlimb / Q000002:abnormalities; D007275:Injections, Intravenous; D008251:Macaca; D010880:Piperidines / Q000633:toxicity*; D011247:Pregnancy; D011760:Pyrrolidinones / Q000633:toxicity*; D011817:Rabbits; D051381:Rats; D013045:Species Specificity; D013131:Spine / Q000002:abnormalities; D013792:Thalidomide / Q000633:toxicity* / Q000031:analogs & derivatives; D013997:Time Factors; D014953:Wrist / Q000002:abnormalities
D010880:Piperidines; D011760:Pyrrolidinones; C001079:2-(2,6-dioxopiperidin-3-yl)phthalimidine; D013792:Thalidomide